SV Health Investors
Investor profile
Venture capital
SV Health Investors has backed 6 European tech companies across 7 funding rounds between 2021 and 2026, joining rounds totalling €650M. Most active in Healthtech. Data as of Nov 2026.
Deals
7
distinct rounds
Companies
6
backed
Active span
2021–2026
6 yrs
Total round €
€650M
sum of rounds joined
Deals by year
distinct rounds / yearSV Health Investors — deals by year — interactive chart.
Data table
| SV Health Investors — deals by year | |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2025 | 3 |
| 2026 | 1 |
Top sectors
by dealsSV Health Investors — top sectors — interactive chart.
Data table
| SV Health Investors — top sectors | |
|---|---|
| Healthtech | 7 |
Stages
by dealsSV Health Investors — stages — interactive chart.
Data table
| SV Health Investors — stages | |
|---|---|
| Series A | 3 |
| Other | 1 |
| Series B | 1 |
| Series C | 1 |
| Series D+ | 1 |
Countries
by dealsSV Health Investors — countries — interactive chart.
Data table
| SV Health Investors — countries | |
|---|---|
| UK | 6 |
| Ireland | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- Janus Henderson Investors3
- Jeito Capital3
- Bain Capital Life Sciences2
- EQT Life Sciences2
- MRL Ventures Fund2
- Omega Funds2
- Samsara Biocapital2
- Syncona Partners2
- Andera Partners1
- Avidity Partners1
- British Business Bank1
- British Patient Capital1
- DCVC Bio1
- Earlybird Venture Capital1
- Fidelity Management & Research Company LLC1
- Forbion1
- GV1
- Invus1
- IP Group PLC1
- Jefferson Life Sciences1
- Lightstone Ventures1
- Lilly1
- M Ventures1
- Monashee Investment Management LLC1
- Northpond Ventures1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| OMass Therapeutics | UK | 1 | €273M |
| Quell Therapeutics | UK | 1 | €138M |
| EyeBiotech | UK | 2 | €118M |
| Artios | UK | 1 | €99M |
| Perfuze | Ireland | 1 | €22M |
| Alchemab Therapeutics | UK | 1 | €0 |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| Quell Therapeutics | Series B | €138M | 2021-11 |
| Artios | Series D+ | €99M | 2025-11 |
| EyeBiotech | Series A | €61M | 2023-11 |
| EyeBiotech | Series A | €57M | 2022-02 |
| Perfuze | Other | €22M | 2025-03 |